IGF2BP3 and laryngeal squamous cell carcinoma: In laryngeal carcinoma, RBM15 and IGF2BP3 are involved in m6A methylation modification of TMBIM6, thereby regulating the expression of TMBIM6 in laryngeal squamous cell carcinoma (LSCC) (27).